Mergers and Acquisitions: Transforming the Global Business Landscape 2026–2030
Historical Context of M&A
Since 1996, India has recorded over 28,500 M&A deals with a cumulative value exceeding $1.06 trillion. In 2025 alone, deal value rose sharply to around $60.2 billion, with transaction volumes reaching 960+ deals, reflecting a strong rebound in high-value activity despite a relatively stable deal count.
Technological Transformation
Technological innovation, particularly AI, blockchain, and digital tools, is a major driver of M&A. AI is transforming the process by streamlining operations, enhancing due diligence, automating tasks, and accelerating data analysis. In the IT sector, AI-driven M&A is rising, with generative AI projected to be used in 80% of M&A processes within three years, up from 16% today.
Landmark M&A Deals (2020–2025)
| Deal | Value | Sector | Strategic Rationale | Market Impact |
|---|---|---|---|---|
| Tesla – Maxwell Technologies (2019) | $218M | Automotive & Energy Storage | Strengthened Tesla's vertical integration in battery innovation. | Enhanced potential for higher energy density and lower cost EV batteries. |
| Amazon – MGM Studios (2021) | $8.45B | Media & Entertainment | Content-driven acquisition to build scale in the attention economy. | Bolstered Amazon Prime Video's library, including iconic IPs like James Bond, for subscriber retention in OTT wars. |
| Microsoft – Activision Blizzard (2022) | $68.7B | Technology & Gaming | A historic gaming deal giving Microsoft scale in gaming and future-ready access to the metaverse ecosystem. | Triggered global competition concerns (US, UK, EU regulators). Cemented Microsoft's position vis-à-vis Sony and Tencent. |
| AMD – Xilinx (2022) | $35B | Semiconductors | Portfolio diversification beyond CPUs/GPUs into adaptive computing and FPGAs. | Elevated AMD as a full-stack semiconductor player competing with Intel and NVIDIA across HPC and AI workloads. |
| Pfizer – Arena Pharmaceuticals (2022) | $6.7B | Pharmaceuticals | Pipeline strengthening in immuno-inflammatory drugs, complementing Pfizer's R&D-led growth. | Accelerated Pfizer's diversification beyond vaccines into chronic-care therapeutics. |
| Oracle – Cerner Corporation (2022) | $28.3B | Healthcare IT | Entry into healthcare data systems, leveraging Oracle's cloud expertise to digitize health records. | Convergence of tech + healthcare signaled digital health's rise as a core growth frontier. |
| Reliance – Disney Merger (2024, Completed) | $8.5B | Media & Entertainment | Consolidation of Star India, Viacom18, JioCinema & Hotstar into JioHotstar, combining TV, digital & sports under one platform. | Commands 120 TV channels, 280M subscribers, >85% OTT share, 50% TV viewership; IPL rights drive mass user engagement. |
| Tata Motors – Iveco (2025) | $4.4–4.5B | Commercial Vehicles Business | Expands Tata Motors globally with access to Europe and Latin America via Iveco Group; accelerates entry into EV and hydrogen technologies; drives scale efficiencies. | Enhances global positioning and investor sentiment; increases competitive pressure in the CV market; short-term leverage concerns but positive long-term outlook. |
Sectoral Analysis of Landmark Deals
| Sector | Key Drivers | Notable Deals |
|---|---|---|
| Technology | Cloud computing, AI, cyber security, and semiconductor advancements | Microsoft–Activision, AMD–Xilinx, Oracle–Cerner |
| Healthcare and Pharmaceuticals | Development of vaccines, immunology, and healthcare IT | Pfizer–Arena Pharmaceuticals, Oracle–Cerner |
| Media and Entertainment | Competition among streaming platforms, global content demand | Amazon–MGM Studios, Reliance–Disney |
| Renewable Energy | Clean energy mandates, carbon neutrality goals | Tesla–Maxwell Technologies |
Implications of Recent Deals
- Market Transformation: These transactions reshaped competitive landscapes, creating opportunities for growth while intensifying competition.
- Regulatory Challenges: Deals faced scrutiny, particularly in technology and media, over antitrust concerns and data privacy issues.
- Strategic Realignments: Companies increasingly focused on vertical integration and technological synergies to drive innovation and efficiency.
Thus, the landmark M&A deals between 2020–2025 underscored consolidation as a key strategy for overcoming challenges and seizing opportunities, driving innovation, transformation, and shaping the future of global business.
The 2025 Performance and Projections for 2026
2025 Overview
India's M&A market witnessed a strong rebound in 2025, with total deal value reaching approximately $60 billion, reflecting robust growth driven by high-value transactions. While overall deal volumes remained relatively stable, the surge in billion-dollar deals significantly boosted aggregate value. The year was marked by increased domestic consolidation and renewed inbound interest, particularly in infrastructure, BFSI, and technology sectors.
Projections for 2026
Looking ahead, India's M&A market is expected to maintain positive momentum, with transaction values projected in the range of $65–75 billion, supported by improving capital availability and strategic consolidation trends. Key drivers include:
- AI & Digital Expansion: Continued investments in AI, cloud, and digital platforms driving strategic acquisitions.
- Infrastructure & Energy Push: Ongoing focus on renewables, logistics, and core infrastructure assets.
- Private Equity Momentum: Sustained recovery with increased dry powder deployment and platform-building strategies.
- Regulatory Stability: Policy continuity and ease of doing business supporting both domestic and cross-border transactions.
Notable Deals Driving Momentum
A. Mankind Pharma's Acquisition of Bharat Serums & Vaccines
Below is a comparative snapshot of Mankind–BSV (2024) vs. Pfizer–Arena Pharma (2022), wherein we can see how Indian pharma M&A trends are converging with global benchmarks.
| Aspect | Mankind Pharma – BSV (2024) | Pfizer – Arena Pharma (2022) |
|---|---|---|
| Deal Value | INR 13,768 Cr (USD 1.65 Bn) | USD 6.7 Bn |
| Stake Acquired | 100% | 100% |
| Funding Structure | Mix of internal accruals + debt (NCDs & CPs); equity raise planned | All-cash transaction |
| Primary Focus | Women's Health, Fertility, Critical Care, Immunoglobulins | Immuno-inflammatory diseases |
| Strategic Significance | Makes Mankind a leader in women's health & fertility in India with access to high entry barrier, niche therapies | Strengthens Pfizer's pipeline in autoimmune & inflammatory diseases and expands innovative medicine portfolio |
| R&D & Innovation | In-house complex biologics, recombinant platforms, niche critical care products | Cutting-edge R&D in immuno-inflammatory drugs |
| Geographic Scope | India leadership + expansion in global fertility/IVF markets | Global R&D and market integration, especially US & EU |
| Financial Impact | EBITDA-margin accretive, Net Debt/EBITDA target <2x by FY26 | Long-term growth through new drug pipeline |
| Workforce Integration | 2,500+ BSV employees added to Mankind | Arena fully absorbed into Pfizer's global R&D and commercial structure |
Key insights:
- Indian M&A catching up to global pharma scale: While smaller in value than Pfizer's mega-deal, Mankind's acquisition is huge by Indian standards, reflecting increasing consolidation in specialty pharma.
- Focus areas diverge but are complementary: Pfizer bet on the future drug pipeline in autoimmune diseases and immunology, while Mankind consolidates existing leadership in women's health, fertility & critical care, while gaining biologics R&D.
- Market Impact: Pfizer's deal was pipeline-driven, betting on future blockbuster drugs; Mankind's deal is portfolio-driven, strengthening current market dominance plus future innovation.
B. ACC–Ambuja Cement's Acquisition of Penna Cement
Transaction Overview
- Acquirer: Ambuja Cements Ltd. (subsidiary of Adani Cement)
- Target: Penna Cement Industries Ltd. (PCIL)
- Stake Acquired: 100%
- Enterprise Value: ₹10,422 Crore
- Completion Date: 16 August 2024
- Deal Type: Strategic acquisition to expand production capacity and geographical presence
Strategic Rationale
- Capacity Expansion: Adds 14 MTPA capacity; supports Ambuja's goal to achieve 140 MTPA capacity by FY2028, representing 16% CAGR growth (current 77.4 MTPA).
- Market Presence: Strengthens footprint in Southern & Eastern India where Ambuja had weaker presence; provides sea-route access to Sri Lanka via Penna's bulk cement terminals (BCTs).
- Resource Advantage: Access to ample limestone reserves ensuring long-term raw material security; surplus clinker from Jodhpur unit can support additional 3 MTPA grinding capacity; enhances economies of scale in production, logistics, and procurement.
Adani Group's Cement Strategy
- Market Share Goal: Capture 20% of India's cement market (currently the second largest after UltraTech Cement).
- Recent Investments: ₹1,600 crore invested in a new grinding unit in Bihar.
- M&A Pipeline: Nearly $3 billion earmarked for acquisitions. Potential targets include Gujarat's Saurashtra Cement, Jaiprakash Associates' cement business, and Vadraj Cement.
| Parameter | Adani Cement | UltraTech Cement |
|---|---|---|
| Current Capacity (FY24) | 91.4 MTPA (Ambuja 77.4 + Penna 14 MTPA, incl. under-construction) | 138.0 MTPA |
| Target Capacity (FY28) | 140 MTPA | 160 MTPA+ (aggressive expansions announced) |
| Market Share (India) | 15% (aiming 20% by FY28) | 23% (market leader) |
| Geographical Presence | Strong in North, West, Central; now expanded to South & East via Penna | Pan-India coverage, especially strong in South & East |
| Strategic Assets | Penna's Bulk Cement Terminals enabling coastal logistics & exports to Sri Lanka; ample limestone reserves; 18 integrated plants + 18 grinding units | 23 integrated plants + 29 grinding units; strong RMC and white cement portfolio; pan India distribution |
| Recent Investments | ₹10,422 Cr for Penna Cement acquisition; ₹1,600 Cr grinding unit in Bihar; $3 Bn earmarked for further M&A | Continuous capex for brownfield expansions; strong focus on renewable & energy efficiency |
| Parent Group Strategy | Vision: 20% market share by FY28, capacity-led aggressive growth, debt-light strategy | Vision: Retain first position in leadership; expand into green cement & global markets |
| Competitive Edge | Fastest-growing player with M&A-led expansion; coastal export potential via Penna's BCTs; backed by Adani infra ecosystem | Scale advantage & brand leadership; extensive retail & RMC presence; established global credibility |
Key Hurdles and Legal Challenges in M&A: Role of CAs
Mergers and Acquisitions are intricate transactions with significant regulatory, financial, and operational challenges. Chartered Accountants play a pivotal role by ensuring compliance, structuring finances efficiently, mitigating risks, and coordinating with legal advisors.
1. Regulatory Compliance Challenges
Domestic Transactions:
- Corporate Laws: CAs must ensure compliance with local laws such as the Companies Act, 2013, which governs shareholder approvals, disclosures, and post-merger filings.
- Sectoral Regulations: Industries such as banking, defense, and telecommunications are subject to additional regulatory scrutiny, requiring prior approvals.
- Competition Law: Approval from authorities like the Competition Commission of India (CCI) is essential to prevent anti-competitive practices.
Cross-Border Transactions:
- Foreign Exchange Laws: Adhering to laws such as the Foreign Exchange Management Act in India is critical for cross-border transactions.
- Antitrust Approvals: M&A deals often require multi-jurisdictional antitrust reviews, such as those by the European Commission or the US Federal Trade Commission.
- Tax Treaties: Structuring deals to leverage Double Taxation Avoidance Agreements (DTAAs) while minimizing tax exposure is a key challenge.
2. Taxation Hurdles
Domestic Transactions:
- Capital Gains Tax: Analyzing and optimizing tax liabilities on the transfer of assets and shares are essential.
- Stamp Duty: Stamp duties on asset transfers vary across states and can significantly impact transaction costs.
Cross-Border Transactions:
- Withholding Taxes: Ensuring compliance with withholding tax regulations on cross-border payments like royalties or dividends.
- Transfer Pricing: Accurate valuation of cross-border transactions to comply with transfer pricing regulations and avoid disputes.
- Tax Jurisdiction Conflicts: Identifying the jurisdiction for taxing income and gains is often contentious in international deals.
3. Due Diligence Complexities
Domestic Transactions:
- Financial Review: Ensuring accuracy of financial statements, contingent liabilities, and compliance with domestic accounting standards.
- Disclosure Norms: Adhering to regulatory disclosure requirements to avoid penalties or delays.
Cross-Border Transactions:
- Diverse Standards: Reconciling varying accounting and legal standards across jurisdictions.
- Language Barriers: Translating and interpreting financial and legal documents from foreign languages accurately.
4. Legal and Structural Hurdles
- Cultural and Governance Differences: Aligning corporate governance and cultural practices in cross-border deals.
- Sanctions and Trade Barriers: Avoiding deals with entities in sanctioned jurisdictions or industries.
- Intellectual Property (IP) Risks: Ensuring seamless transfer and protection of intellectual property rights (IPR).
5. Securities and Disclosure Regulations
- Takeover Code Compliance: Public company acquisitions require adherence to laws like SEBI (SAST) Regulations in India.
- Insider Trading Laws: Preventing misuse of confidential information during the transaction process.
- Disclosure Obligations: Accurate and timely reporting to regulators and stakeholders.
6. Labor and Employment Laws
- Employee Benefits Harmonization: Aligning employee contracts, pensions, and benefits across merging entities.
- Workforce Relocation: Addressing visa and immigration challenges in cross-border workforce integration.
- Jurisdiction-Specific Protections: Compliance with worker protection laws, including mandatory consultations in some jurisdictions.
7. Data Protection and Privacy Laws
- GDPR Compliance: Ensuring compliance with the EU's General Data Protection Regulation (GDPR) in cross-border transactions.
- Data Localization Laws: Adhering to jurisdiction-specific data residency requirements.
8. Emerging Challenges
- ESG Compliance: Integrating Environmental, Social, and Governance factors into M&A processes is becoming increasingly important.
- Technological Integration: Merging IT systems and ensuring cyber security in the newly formed entity.
- Litigation Risks: Managing disputes arising from breach of warranties or misrepresentation.
Major post-integration risks include operational alignment (harmonizing operational systems and processes), repatriation of profits (addressing restrictions on profit repatriation to parent jurisdictions), and environmental compliance (addressing liabilities for past environmental violations of the target company).
Emerging Trends Shaping M&A (2026–2030)
- Sustainability and Clean Energy: M&A activity in clean energy is expected to accelerate, driven by government initiatives to achieve 500 GW of clean energy capacity by 2030. Companies are increasingly focusing on ESG criteria as a cornerstone of their growth strategies.
- Digital Transformation: The integration of AI, blockchain, and IoT is reshaping industries, creating opportunities for technology-driven mergers.
- Healthcare and Pharmaceuticals: Post-pandemic, the healthcare sector has witnessed consolidation, with companies focusing on innovation and expanding their product portfolios.
- Infrastructure and Real Estate: The construction boom and urbanization trends in emerging markets have sparked significant M&A interest, with companies leveraging deals to access prime locations, streamline supply chains, and capitalize on smart city projects.
The Role of Chartered Accountants (CAs) in M&A: Opportunities and Services
Strategic Planning and Advisory
- Identify potential targets aligned with industry trends and goals.
- Advise on deal structures (asset/share purchases, JVs).
- Conduct market research to assess competitiveness and growth prospects.
Valuation and Financial Modeling
- Perform valuations (DCF, Comparable Companies, Precedent Transactions).
- Build financial models to forecast performance and synergies.
Tax Structuring and Optimization
- Structure deals to minimize tax liabilities and ensure compliance.
- Use tax treaties to avoid double taxation and optimize cash flows.
Due Diligence Services
- Carry out financial, legal, and operational due diligence.
- Verify financial statements and uncover risks or compliance gaps.
Regulatory Compliance and Risk Management
- Ensure compliance with corporate, tax, and securities laws.
- Manage approvals from regulators (e.g., competition authorities).
Transaction Support Services
- Assist in negotiating deal terms, warranties, and indemnities.
- Draft financial sections of shareholder and regulatory filings.
Post-Merger Integration (PMI)
- Align accounting systems, reporting, and processes.
- Track achievement of synergies and financial targets.
Audit and Assurance Services
- Provide assurance on financial disclosures and reporting standards.
- Conduct special audits for acquisition-related statements.
Advisory on ESG
- Integrate ESG factors into M&A to create long-term value.
- Guide sustainability reporting and ESG compliance.
Technological Integration and Cyber Security
- Support IT and digital system integration.
- Ensure robust cyber security during and post-deal.
Thus, the roles of CAs are pivotal in M&A, offering expertise across strategy, finance, compliance, and integration. Their role ensures smooth execution, risk management, and value creation, making them indispensable in today's complex deal environment.
Observational Insight (2025)
- Technology, infrastructure, and financial services dominated deal value concentration.
- Mega-deals ($10B+) largely driven by scale, AI capability, and infrastructure control.
- Increasing cross-border strategic acquisitions, especially from emerging markets like India.
Sector-wise Share of M&A Deals (Volume, 2025–26 est.)
| Sector | Approx. Share |
|---|---|
| IT / Technology | 24% |
| Industrials / Manufacturing | 15% |
| Utilities / Power / Renewable | 13% |
| Healthcare / Pharma | 10% |
| Financial Services / Insurance | 9% |
| Consumer Goods / FMCG | 8% |
| Telecom / Infrastructure | 7% |
| Others (incl. gaming, retail, energy) | 14% |
Future Outlook (2030 Projections)
Global M&A is set to grow strongly, led by clean energy, technology, and healthcare. India is expected to emerge as a global hub for strategic investments with exponential M&A growth.
Key Trends:
- Rise in cross-border collaborations.
- Stronger focus on sustainability and ESG.
- Expansion of private equity and venture capital in early-stage firms.
Conclusion
M&A will remain central to corporate growth and innovation, with India's dynamic market, supported by regulatory reforms and proactive policies, playing a pivotal role in global economic progress through 2026–2030.
References
- Bain & Company. "Looking Back: M&A Report 2025." Retrieved from: bain.com
- Reuters. "Law Firms Rode Uneven M&A Wave as Big Deals Surged in 2024." Retrieved from: reuters.com
- Financial Times. "Dealmakers Bet That Donald Trump Will Fuel Rebound in Megadeals." Retrieved from: ft.com
- MarketWatch. "Merger Activity is Down 40% from its Peak. Citigroup CEO Jane Fraser Sees a 'Big Unlock' Ahead." Retrieved from: marketwatch.com
- Financial Times, India Briefing
- cfo.economictimes.indiatimes.com